Birdwatch Note
2023-11-07 21:56:57 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
L'étude n'a pas obtenu l'autorisation de l'ANSM et l'avis favorable d'un comité de protection des personnes, nécessaires et obligatoires pour garantir la sécurité des patients, comme lors du pre-print. https://www.lepoint.fr/societe/une-nouvelle-etude-de-didier-raoult-fermement-condamnee-par-les-autorites-07-11-2023-2542225_23.php https://www.rtl.fr/actu/sante/etude-co-signee-par-didier-raoult-sur-l-hydroxychloroquine-l-ansm-saisit-la-justice-7900272549 L'ANSM avait déjà saisi la justice en 2022 après un rapport de l'IGAS https://www.igas.gouv.fr/IMG/pdf/2014-117R_-_IHU.pdf
Written by 5DCB403CB3AC8BE7081D36BCA81E2A4814385144CF67CD19F882F7CC890D614D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1721929882152718336
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1722010275350556797
- noteId - 1722010275350556797
- participantId -
- noteAuthorParticipantId - 5DCB403CB3AC8BE7081D36BCA81E2A4814385144CF67CD19F882F7CC890D614D Participant Details
- createdAtMillis - 1699394217703
- tweetId - 1721929882152718336
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- L'étude n'a pas obtenu l'autorisation de l'ANSM et l'avis favorable d'un comité de protection des personnes, nécessaires et obligatoires pour garantir la sécurité des patients, comme lors du pre-print. https://www.lepoint.fr/societe/une-nouvelle-etude-de-didier-raoult-fermement-condamnee-par-les-autorites-07-11-2023-2542225_23.php https://www.rtl.fr/actu/sante/etude-co-signee-par-didier-raoult-sur-l-hydroxychloroquine-l-ansm-saisit-la-justice-7900272549 L'ANSM avait déjà saisi la justice en 2022 après un rapport de l'IGAS https://www.igas.gouv.fr/IMG/pdf/2014-117R_-_IHU.pdf
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-11-07 21:56:57 UTC (1699394217703) |
2023-11-08 00:49:01 UTC (1699404541757) |
CURRENTLY_RATED_HELPFUL | 2023-11-08 03:19:21 UTC (1699413561605) |
CURRENTLY_RATED_HELPFUL | 2023-11-08 00:49:01 UTC (1699404541757) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-11-07 18:31:54 -0600 | Rating Details | |
2023-11-07 18:05:00 -0600 | Rating Details | |
2023-11-07 17:56:22 -0600 | Rating Details | |
2023-11-07 17:51:44 -0600 | Rating Details | |
2023-11-07 17:49:31 -0600 | Rating Details | |
2023-11-07 17:42:33 -0600 | Rating Details | |
2023-11-07 17:42:05 -0600 | Rating Details | |
2023-11-07 17:33:43 -0600 | Rating Details | |
2023-11-07 17:31:41 -0600 | Rating Details | |
2023-11-07 17:31:02 -0600 | Rating Details | |
2023-11-07 17:19:59 -0600 | Rating Details | |
2023-11-07 17:04:27 -0600 | Rating Details | |
2023-11-07 17:03:17 -0600 | Rating Details | |
2023-11-07 16:57:22 -0600 | Rating Details | |
2023-11-07 16:48:48 -0600 | Rating Details | |
2023-11-07 16:45:31 -0600 | Rating Details | |
2023-11-07 16:41:05 -0600 | Rating Details | |
2023-11-07 16:39:46 -0600 | Rating Details | |
2023-11-07 16:38:26 -0600 | Rating Details | |
2023-11-07 16:37:45 -0600 | Rating Details | |
2023-11-07 16:36:46 -0600 | Rating Details | |
2023-11-07 16:36:22 -0600 | Rating Details | |
2023-11-07 16:35:42 -0600 | Rating Details | |
2023-11-07 16:35:19 -0600 | Rating Details | |
2023-11-07 16:34:45 -0600 | Rating Details | |
2023-11-07 16:34:30 -0600 | Rating Details | |
2023-11-07 16:34:18 -0600 | Rating Details | |
2023-11-07 16:33:46 -0600 | Rating Details | |
2023-11-07 16:33:43 -0600 | Rating Details | |
2023-11-07 16:33:40 -0600 | Rating Details | |
2023-11-07 16:30:32 -0600 | Rating Details | |
2023-11-07 16:30:16 -0600 | Rating Details | |
2023-11-07 16:29:50 -0600 | Rating Details | |
2023-11-07 16:29:44 -0600 | Rating Details | |
2023-11-07 16:29:03 -0600 | Rating Details | |
2023-11-07 16:28:49 -0600 | Rating Details | |
2023-11-07 16:26:59 -0600 | Rating Details | |
2023-11-07 16:26:22 -0600 | Rating Details | |
2023-11-07 16:23:07 -0600 | Rating Details | |
2023-11-07 16:22:12 -0600 | Rating Details | |
2023-11-07 16:21:37 -0600 | Rating Details | |
2023-11-07 16:21:07 -0600 | Rating Details | |
2023-11-07 16:17:27 -0600 | Rating Details | |
2023-11-07 16:10:59 -0600 | Rating Details | |
2023-11-07 16:10:02 -0600 | Rating Details | |
2023-11-07 16:00:45 -0600 | Rating Details | |
2023-11-07 16:00:12 -0600 | Rating Details | |
2023-11-08 14:34:18 -0600 | Rating Details | |
2023-11-08 11:52:58 -0600 | Rating Details | |
2023-11-08 11:18:21 -0600 | Rating Details | |
2023-11-08 09:57:39 -0600 | Rating Details | |
2023-11-08 09:41:17 -0600 | Rating Details | |
2023-11-08 09:18:00 -0600 | Rating Details | |
2023-11-08 08:12:39 -0600 | Rating Details | |
2023-11-08 06:34:43 -0600 | Rating Details | |
2023-11-08 06:27:53 -0600 | Rating Details | |
2023-11-08 05:57:08 -0600 | Rating Details | |
2023-11-08 05:01:24 -0600 | Rating Details | |
2023-11-08 03:29:43 -0600 | Rating Details | |
2023-11-08 03:19:27 -0600 | Rating Details | |
2023-11-08 02:53:38 -0600 | Rating Details | |
2023-11-08 02:51:00 -0600 | Rating Details | |
2023-11-08 02:35:36 -0600 | Rating Details | |
2023-11-08 02:20:16 -0600 | Rating Details | |
2023-11-08 02:13:35 -0600 | Rating Details | |
2023-11-08 01:57:47 -0600 | Rating Details | |
2023-11-08 01:53:10 -0600 | Rating Details | |
2023-11-08 01:20:52 -0600 | Rating Details | |
2023-11-08 01:09:31 -0600 | Rating Details | |
2023-11-08 01:07:46 -0600 | Rating Details | |
2023-11-08 00:57:22 -0600 | Rating Details | |
2023-11-08 00:33:19 -0600 | Rating Details | |
2023-11-08 00:26:40 -0600 | Rating Details | |
2023-11-08 00:18:53 -0600 | Rating Details | |
2023-11-08 00:13:40 -0600 | Rating Details | |
2023-11-08 00:13:23 -0600 | Rating Details | |
2023-11-08 00:04:58 -0600 | Rating Details | |
2023-11-08 00:01:49 -0600 | Rating Details | |
2023-11-07 23:47:34 -0600 | Rating Details | |
2023-11-07 23:17:55 -0600 | Rating Details | |
2023-11-07 22:59:26 -0600 | Rating Details | |
2023-11-07 22:26:40 -0600 | Rating Details | |
2023-11-07 22:23:56 -0600 | Rating Details | |
2023-11-07 20:32:19 -0600 | Rating Details | |
2023-11-07 20:30:58 -0600 | Rating Details | |
2023-11-07 20:08:38 -0600 | Rating Details | |
2023-11-07 19:58:40 -0600 | Rating Details | |
2023-11-07 19:51:31 -0600 | Rating Details | |
2023-11-07 18:46:06 -0600 | Rating Details | |
2023-11-09 15:50:23 -0600 | Rating Details | |
2023-11-09 15:41:44 -0600 | Rating Details | |
2023-11-09 11:35:58 -0600 | Rating Details | |
2023-11-09 07:25:22 -0600 | Rating Details | |
2023-11-09 05:47:43 -0600 | Rating Details | |
2023-11-09 04:36:18 -0600 | Rating Details | |
2023-11-09 03:47:38 -0600 | Rating Details | |
2023-11-09 02:36:28 -0600 | Rating Details | |
2023-11-09 00:34:06 -0600 | Rating Details | |
2023-11-08 05:36:32 -0600 | Rating Details | |
2023-11-10 02:36:50 -0600 | Rating Details | |
2023-11-10 00:22:46 -0600 | Rating Details | |
2023-11-11 17:35:09 -0600 | Rating Details | |
2023-11-11 10:58:09 -0600 | Rating Details | |
2023-11-16 13:23:12 -0600 | Rating Details | |
2023-11-10 01:14:19 -0600 | Rating Details | |
2023-11-29 12:38:50 -0600 | Rating Details |